Jagiellonian University Repository

Kidney dysfunction after non renal solid organ transplantation

Communities & Collections

pcg.skipToMenu

Kidney dysfunction after non renal solid organ transplantation

Show full item record

dc.contributor.author Malyszko, Jolanta pl
dc.contributor.author Durlik, Magdalena pl
dc.contributor.author Przybyłowski, Piotr [SAP20001438] pl
dc.date.accessioned 2020-04-03T13:21:05Z
dc.date.available 2020-04-03T13:21:05Z
dc.date.issued 2009 pl
dc.identifier.issn 1425-9524 pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/153187
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/pl/legalcode *
dc.title Kidney dysfunction after non renal solid organ transplantation pl
dc.type JournalArticle pl
dc.description.physical 71-79 pl
dc.description.additional Bibliogr. s. 77-79 pl
dc.identifier.weblink http://www.annalsoftransplantation.com/fulltxt.php?ICID=900247 pl
dc.abstract.en Chronic kidney disease developed after non renal solid organ transplantation in a significant issue. Evaluation of kidney function starting form a complete history and physical examination, then an accurate measurement of renal function and a urinalysis, followed by kidney imaging study should be performed prior to transplantation. Moreover, probability of reversibility of kidney dysfunction and the risk of progression to end stage renal disease should be assessed. During periand postoperative period hypotensive episodes should be avoided or at least minimized. Good blood pressure control (however, no guidelines for target blood pressure values for non solid organ transplants are available) as well as tight control of diabetes and hyperlipidemia should be implemented. Proteinuria, if present, should be attenuated by the use of therapeutic modalities (RAS blockade) to prevent or delay the progression of renal failure. The ability to identify CKD may allow early implementation of treatments that could arrest or delay the progression of renal damage, enable effective treatment of its complications, and reduce the risk of drug-induced nephrotoxicity. Kidney function should be monitored in nonrenal solid organ transplant recipients as an important risk factor comparable with diabetes for cardiovascular mortality and morbidity. In presence of existing nephron sparing immunosuppressive regimens, early detection of deteriorating kidney function gives the opportunity to tailor the treatment. A multidisciplinary approach for these patients including also a nephrologist should be considered. pl
dc.subject.en chronic kidney disease pl
dc.subject.en heart transplantation pl
dc.subject.en kidney transplantation pl
dc.subject.en liver transplantation pl
dc.description.volume 14 pl
dc.description.number 4 pl
dc.description.publication 1 pl
dc.identifier.eissn 2329-0358 pl
dc.title.journal Annals of Transplantation pl
dc.language.container eng pl
dc.date.accession 2020-04-03 pl
dc.affiliation Wydział Lekarski : Klinika Chirurgii Ogólnej, Onkologicznej i Gastroenterologicznej pl
dc.subtype Article pl
dc.rights.original CC-BY-NC-ND; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl


Files in this item

Name: malyszko_durlik_p ...
Size: 262.4Kb
Format: PDF
View/Open
Icon
Name: malyszko_durlik_p ...
Size: 150.7Kb
Format: OpenOffice Writer
View/Open

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa